Randomized Controlled Trial to Evaluate Para-Aortic Lymphadenectomy for Gastric Cancer (JCOG9501)
Radical gastrectomy with regional lymphadenectomy is the only curative treatment option for
gastric cancer. The extent of lymphadenectomy, however, is controversial. The two European
randomized trials only reported an increase in operative morbidity and mortality, but failed
to show survival benefit, in the D2 lymphadenectomy group. We conducted a randomized
controlled trial to compare the Japanese standard D2 and D2 + para-aortic nodal dissection.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
overall survival
Mitsuru Sasako, MD
Study Chair
Gastric Surgery Division, National Cancer Center Hospital
Japan: Ministry of Health, Labor and Welfare
JCOG9501
NCT00149279
July 1995
April 2006
Name | Location |
---|